Precision Business Insights
Portfolio

 

Research Reports

Venous Thromboembolism Devices Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023

Global Venous Thromboembolism Devices Market: Venous thromboembolism is a disease caused by the clotting of blood in the blood vessel which leads to restriction of blood flow within the circulatory system. It is classified into pulmonary embolism and deep vein thrombosis. Deep vein thrombosis is mainly occurred due to clotting of blood in deep vein (commonly in the leg). The formed DVT clot breaks off and flows to lungs known as pulmonary embolism which is a severe complication of deep vein thrombosis (DVT). Venous thromboembolism commonly occurs in aged persons with more than 60 years. People with overweight, persons with thicker blood and persons suffering from autoimmune disorders such as (lupus, rheumatoid arthritis etc.) or cancer are at higher risk of venous thromboembolism. Venous thromboembolism can cause chronic complications, such as post-thrombotic syndrome (PTS) or chronic thromboembolic pulmonary hypertension (CTEPH). The symptoms associated with the venous thromboembolism include dilated blood veins in legs and chest, oedema, fever, tachycardia, and dyspnoea. Lower extremities are the most common site for DVT, but other locations affected include the mesenteric, upper extremities, pelvic veins, and cerebral veins.

 

Global Venous Thromboembolism Devices Market Outlook

 

The Venous Thromboembolism Devices Market is growing at a significant CAGR due to increase in geriatric population. Rise in government expenditure, increasing incidence of venous thromboembolism, and high unmet needs of currently available treatment procedures are fuelling the venous thromboembolism devices market. For instance, in 2014 May, U.S. FDA issued post market surveillance study for inferior vena cava filters which provides information regarding implementation of the filters and risks of pulmonary thromboembolism. Furthermore, increase in surgical procedures such as hip and knee replacements that are risk factors for venous thromboembolism conditions. Growing patient awareness regarding venous thromboembolism conditions expected to boost the venous thromboembolism devices market over the forecast period.  However, high cost of deep vein thrombosis treatment, difficult pathophysiology of the venous thromboembolism hinders the growth of venous thromboembolism devices market. Similarly, stringent regulatory approvals for the development of products are expected to dampen growth of venous thromboembolism devices market over the forecast period.

 

 

The venous thromboembolism devices market is segmented on the basis of product type, disease type, and end user

 

Based on type of device, venous thromboembolism devices market is segmented into the following

 

  • Compression Stockings
  • Gradual or medical compression stockings
  • Anti-embolism stockings
  • Nonmedical support hosiery
  • Intermitted pneumatic compression devices
  • Inferior vena cava filters
  • Retrievable IVC filters
  • Permanent IVC Filters

 

 

Based on disease type, the venous thromboembolism devices market is segmented into the following

 

  • Deep vein thrombosis
  • Pulmonary embolism

 

 

Based on end-user, the venous thromboembolism devices market is segmented into the following

 

  • Hospitals
  • Diagnostic centres
  • Ambulatory surgical centres

 

Globally, venous thromboembolism devices market is expected to grow at expeditiously owing to increase in incidences of venous thromboembolism conditions. Several local and international players are actively involved in growth of venous thromboembolism devices market. The growth of venous thromboembolism devices market is increased due to rise in prevalence of venous thromboembolism (According to the International Society on Thrombosis and Haemostasis, Inc. (ISTH), approximately 10 Mn cases of venous thromboembolism occur annually). The most commonly adopted strategies by industry players include new product launches with technological innovations, new product approvals, acquisitions & mergers, agreements, and collaborations to capture significant venous thromboembolism Devices Market share.

 

Geographically, venous thromboembolism devices market has been segmented into following regions Viz. North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa. North America anticipated to hold the largest share in the venous thromboembolism devices market owing to increase in the incidence (According to U.S. International Society on Thrombosis and Haemostasis, Inc. (ISTH) there are around 100,000 to 300,000 venous thromboembolism related deaths reported annually) and prevalence rate, rise in demand for advanced treatment, and increase in aging population in the North America region may hold the largest share. Moreover, high healthcare expenditure, high awareness regarding the disease and treatments, and increase in prevalence rate are expected to create demand in Europe region. Asia-Pacific is a key region for venous thromboembolism devices market due to increase in the government expenditure and healthcare infrastructure.

 

Some of the players in venous thromboembolism devices market are Fukuda Denshi Co., Ltd (Japan), Baxter International Inc. (U.S), Lidco Group Plc. (U.K), All Pro Corporation (China), Abbott Laboratories (U.S), Accellent, Inc.(U.S), Cardiva Medical, Inc.(U.S), Biosensors International Group, Ltd.(Singapore), 3M Healthcare (U.S), and others.

 

  • In 2014 January, Argon Medical devices received U.S. FDA 510K Clearance for its ELITE retrievable IVC filter.

 

  • In 2013, Volcano Corporation launched Crux Vena cava filter in U.S. for treatment of venous embolisms.

 

 

 

Report Outline:

  • The report provides granular level information about the market size, regional market share, and forecast from 2017-2023
  • The report covers in-detail insights about the competitor’s overview, key findings, and their key strategies
  • The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
  • The report tracks recent innovations, key developments, and startup’s details that are working in the industry
  • The report provides plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • Fukuda Denshi Co., Ltd (Japan)
  • Baxter International Inc. (U.S)
  • Lidco Group Plc. (U.K)
  • All Pro Corporation (China)
  • Abbott Laboratories (U.S)
  • Accellent, Inc.(U.S)
  • Cardiva Medical, Inc.(U.S)
  • Biosensors International Group, Ltd.(Singapore)
  • 3M Healthcare (U.S)

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements